194 related articles for article (PubMed ID: 3940648)
1. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.
Johnson VG; Schlom J; Paterson AJ; Bennett J; Magnani JL; Colcher D
Cancer Res; 1986 Feb; 46(2):850-7. PubMed ID: 3940648
[TBL] [Abstract][Full Text] [Related]
2. Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3.
Sheer DG; Schlom J; Cooper HL
Cancer Res; 1988 Dec; 48(23):6811-8. PubMed ID: 3180090
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the shed form of the human tumor-associated glycoprotein (TAG-72) from serous effusions of patients with different types of carcinomas.
Katari RS; Fernsten PD; Schlom J
Cancer Res; 1990 Aug; 50(16):4885-90. PubMed ID: 2379152
[TBL] [Abstract][Full Text] [Related]
4. Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.
Kuroki M; Fernsten PD; Wunderlich D; Colcher D; Simpson JF; Poole DJ; Schlom J
Cancer Res; 1990 Aug; 50(16):4872-9. PubMed ID: 1696162
[TBL] [Abstract][Full Text] [Related]
5. Purification and composition of a novel gastrointestinal tumor-associated glycoprotein expressing sialylated lacto-N-fucopentaose II (CA 19-9).
Klug TL; LeDonne NC; Greber TF; Zurawski VR
Cancer Res; 1988 Mar; 48(6):1505-11. PubMed ID: 2449952
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and immunological properties of the human carcinoma-associated CAR-3 epitope defined by the monoclonal antibody AR-3.
Prat M; Medico E; Rossino P; Garrino C; Comoglio PM
Cancer Res; 1989 Mar; 49(6):1415-21. PubMed ID: 2466553
[TBL] [Abstract][Full Text] [Related]
7. Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein.
Horan Hand P; Colcher D; Salomon D; Ridge J; Noguchi P; Schlom J
Cancer Res; 1985 Feb; 45(2):833-40. PubMed ID: 3881173
[TBL] [Abstract][Full Text] [Related]
8. Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene.
Dahiya R; Kwak KS; Byrd JC; Ho S; Yoon WH; Kim YS
Cancer Res; 1993 Mar; 53(6):1437-43. PubMed ID: 8443822
[TBL] [Abstract][Full Text] [Related]
9. Glycolipid-directed FH6 monoclonal antibody recognizes high molecular weight glycoprotein antigen carrying sialyl Lex-i determinant in the culture supernatant of PC-9 cells.
Yamagata Y; Shigeta K; Masuda T; Imura H; Murachi T; Kannagi R; Shin S; Tachikawa T; Noda A; Ohe Y
J Mol Recognit; 1988 Jun; 1(3):111-5. PubMed ID: 2908504
[TBL] [Abstract][Full Text] [Related]
10. Colonic tumor membrane-associated glycoprotein: isolation of antigenically-active peptides after chemical cleavage.
Leung JP; Eshdat Y; Marchesi VT
J Immunol; 1977 Aug; 119(2):664-70. PubMed ID: 69665
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of the human adenocarcinoma-associated glycoprotein gp40.
Sportsman JR; Taber LD; Slisz MC; Apelgren LD; Bumol TF
Biotechnol Appl Biochem; 1988 Dec; 10(6):536-44. PubMed ID: 3069116
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas.
Sekine H; Ohno T; Kufe DW
J Immunol; 1985 Nov; 135(5):3610-5. PubMed ID: 4045199
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody against human colonic sulfomucin: immunochemical detection of its binding sites in colonic mucosa, colorectal primary carcinoma, and metastases.
Yamori T; Ota DM; Cleary KR; Hoff S; Hager LG; Irimura T
Cancer Res; 1989 Feb; 49(4):887-94. PubMed ID: 2912559
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition.
Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE
Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955
[TBL] [Abstract][Full Text] [Related]
15. Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line.
Ho JJ; Bi N; Siddiki B; Chung YS; Yuan M; Kim YS
Cancer Res; 1993 Feb; 53(4):884-90. PubMed ID: 7679052
[TBL] [Abstract][Full Text] [Related]
16. [Preparation and identification of monoclonal antibodies against different epitopes on TAG-72 antigen].
Xu M
Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):431-4. PubMed ID: 7515344
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated glycoprotein expression in salivary gland mucoepidermoid carcinomas: an immunohistochemical study using the monoclonal antibody B72.3.
Roa RA; Hruban RH; McKenzie P; Richtsmeier W
Laryngoscope; 1994 Mar; 104(3 Pt 1):304-8. PubMed ID: 8127187
[TBL] [Abstract][Full Text] [Related]
19. Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant.
Osinaga E; Pancino G; Porchet N; Berois N; De Cremoux P; Mistro D; Aubert JP; Calvo F; Roseto A
Breast Cancer Res Treat; 1994; 32(2):139-52. PubMed ID: 7532464
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the antigen recognized by monoclonal antibody 1D3.
Gangopadhyay A; Chatterjee SK; Bhattacharya M; Barlow JJ
Cancer Biochem Biophys; 1988 Nov; 10(2):107-15. PubMed ID: 3252956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
